433 related articles for article (PubMed ID: 12204898)
1. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
Sano H; Sohma H; Muta T; Nomura S; Voelker DR; Kuroki Y
J Immunol; 1999 Jul; 163(1):387-95. PubMed ID: 10384140
[TBL] [Abstract][Full Text] [Related]
3. Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages.
Stamme C; Walsh E; Wright JR
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):772-9. PubMed ID: 11104730
[TBL] [Abstract][Full Text] [Related]
4. Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein.
García-Verdugo I; Sánchez-Barbero F; Soldau K; Tobias PS; Casals C
Biochem J; 2005 Oct; 391(Pt 1):115-24. PubMed ID: 15932345
[TBL] [Abstract][Full Text] [Related]
5. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
[TBL] [Abstract][Full Text] [Related]
7. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-binding protein accelerates and augments Escherichia coli phagocytosis by alveolar macrophages.
Klein RD; Su GL; Schmidt C; Aminlari A; Steinstraesser L; Alarcon WH; Zhang HY; Wang SC
J Surg Res; 2000 Dec; 94(2):159-66. PubMed ID: 11104656
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.
Martin TR; Mathison JC; Tobias PS; Letúrcq DJ; Moriarty AM; Maunder RJ; Ulevitch RJ
J Clin Invest; 1992 Dec; 90(6):2209-19. PubMed ID: 1281827
[TBL] [Abstract][Full Text] [Related]
12. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I
Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918
[TBL] [Abstract][Full Text] [Related]
13. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
14. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages.
Stamme C; Wright JR
Am J Physiol; 1999 Mar; 276(3):L540-7. PubMed ID: 10070120
[TBL] [Abstract][Full Text] [Related]
16. Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 beta.
Wong HR; Pitt BR; Su GL; Rossignol DP; Steve AR; Billiar TR; Wang SC
Am J Respir Cell Mol Biol; 1995 Apr; 12(4):449-54. PubMed ID: 7695925
[TBL] [Abstract][Full Text] [Related]
17. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
Heumann D; Gallay P; Barras C; Zaech P; Ulevitch RJ; Tobias PS; Glauser MP; Baumgartner JD
J Immunol; 1992 Jun; 148(11):3505-12. PubMed ID: 1375247
[TBL] [Abstract][Full Text] [Related]
18. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
19. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation.
Hamann L; Schumann RR; Flad HD; Brade L; Rietschel ET; Ulmer AJ
Eur J Immunol; 2000 Jan; 30(1):211-6. PubMed ID: 10602043
[TBL] [Abstract][Full Text] [Related]
20. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14.
Yu B; Wright SD
J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
